Antiphospholipid antibodies: Basic immunology and assays

Seminars in Arthritis and Rheumatism

Volumn 26, Issue 5, 1997, Pages 724-739

  Schultz, D R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

antiphospholipid antibodies; cardiolipin; lupus anticoagulant; Phospholipids; 2 glycoprotein I

Indexed keywords

AMPHOLYTE; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 11; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; REAGINIC ANTIBODY; THROMBOPLASTIN;

ANTIGENICITY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CONSENSUS SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RECURRENT ABORTION; REVIEW; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0030931311     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(97)80041-8     Document Type: Article

References (123)

1. (chap 12) Stryer L. Introduction to biological membranes Biochemistry 3rd ed. 1988 WH Freeman & Company New York 283 312
2. Kataoka T. Nojima S. Immunochemical studies of phospholipids. VI. Haptenic activity of phosphatidylinositol and the role of lecithin as an auxiliary lipid J Immunol 105 1970 502 511
3. Tamamura S. Hashimoto T. Hara I. The immunological relations between acid phospholipids and their antibodies Jpn J Exp Med 41 1971 31 38
4. Harris E.N. Gharavi A.E. Tincani A. Affinity purified anti-cardiolipin and anti-DNA antibodies J Clin Lab Immunol 17 1985 155 162
5. Harris E.N. Gharavi A.E. Loizou S. Cross reactivity of antiphospholipid antibodies J Clin Lab Immunol 16 1985 1 6
6. Harris E.N. Gharavi A.E. Hughes G.R.V. Anti-phospholipid antibodies Clin Rheum Dis 11 1985 591 609
7. Gharavi A.E. Harris E.N. Asherson R.A. Anticardiolipin antibodies: isotype distribution and phospholipid specificity Ann Rheum Dis 46 1987 1 6
8. Vlachoyiannopoulos P.G. Beigbeder G. Dueymes M. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and β2-glycoprotein I plasma levels Autoimmunity 16 1993 245 249
9. Cabral A.R. Cabiedes J. Alarcon-Segovia D. Haemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelin-treated human erythrocytes J Autoimmunol 3 1990 773 787
10. Triplett D.A. New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies Haemostasis 24 1994 155 164
11. Wassermann A. Neisser A. Bruck C. Eine serodiagnostische reaktion bei syphilis Dtsch Med Wochenschr 32 1906 745 746
12. Pangborn M.C. A simplified preparation of cardiolipin, with a note on purification of lecithin for serologic use J Biol Chem 161 1945 71 82
13. Kahn R.L. McDermott E.B. Universal serologic reaction with lipid antigen. III. In syphilis Am J Clin Pathol 19 1949 401 407
14. Fiumara N.J. Biologic false positive reaction for syphilis N Engl J Med 268 1963 402 405
15. McNeil H.P. Chesterman C.N. Krills S.A. Immunology and clinical importance of antiphospholipid antibodies Adv Immunol 49 1991 193 259
16. Moore J.E. Mohr C.F. Biologically false positive serologic tests for syphilis JAMA 150 1952 467 473
17. Moore J.E. Lutz W.B. The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors J Chronic Dis 1 1955 297 316
18. Haserick J.R. Long R. Systemic lupus erythematosus preceded by false positive test for syphilis: presentation of five cases Ann Intern Med 37 1951 559 565
19. Harvey A.M. Shulman L.E. Connective tissue disease and the chronic biologic false positive test for syphilis Med Clin North Am 50 1966 1271 1279
20. McNeil H.P. Simpson R.J. Chesterman C.N. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H) Proc Natl Acad Sci USA 87 1990 4120 4124
21. Galli M. Comfurius P. Maassen C. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1990 1544 1547
22. Matsuura E. Igarashi Y. Fujimoto M. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Lancet 336 1990 177 178
23. Matsuura E. Igarashi Y. Fujimoto M. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor J Immunol 148 1992 3885 3891
24. Hunt J.E. McNeil H.P. Morgan G.J. A phospholipid β2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection Lupus 1 1992 75 81
25. Asherson R.A. Cervera R. Piette J.-C. Shoenfeld Y. The Antiphospholipid Syndrome 1996 CRC Press Boca Raton, FL 3 12
26. Asherson R.A. Cervera R. Piette J.-C. Shoenfeld Y. The Antiphospholipid Syndrome 1996 CRC Press Boca Raton, FL 29 48 (Chapt 3)
27. Hughes G.R.V. Khamashta M.A. The antiphospholipid syndrome J R Coll Phys Lond 28 1994 301 304
28. Gharavi A.E. Aron A.L. Experimental models for antiphospholipid studies Haemostasis 24 1994 204 207
29. Norden D.K. Ostrov B.E. Shafritz A.B. Vasculitis associated with antiphospholipid syndrome Semin Arthritis Rheum 24 1995 273 281
30. Cervera R. Asherson R.A. Lie J.T. Clincopathologic correlations of the antiphospholipid syndrome Semin Arthritis Rheum 24 1995 262 272
31. Aron A.L. Gharavi A.E. Shoenfeld Y. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome Int Arch Allergy Immunol 106 1995 8 12
32. Belmont H.M. Abramson S.B. Lie J.T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium Arthritis Rheum 39 1996 9 22
33. Schultze H.E. Heide K. Haupt H. Über ein bisher unbekanntes niedermoleculares β2-globulin des Human Serums Naturwissenschaften 48 1961 719
34. Steinkasserer A. Estaller C. Weiss E.H. Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I Biochem J 277 1991 387 391
35. Gries A. Nimpf J. Wurm H. Characterization of isoelectric subspecies of asialo-β2-glycoprotein I Biochem J 260 1989 531 554
36. Lozier J. Takahashi N. Putnam F.W. Complete amino acid sequence of human plasma β2-glycoprotein I Proc Natl Acad Sci USA 81 1984 3640 3644
37. Reid K.B.M. Day A.J. Structure-function relationships of the complement components Immunol Today 10 1989 177 180
38. Schousboe I. Binding of β2-glycoprotein I to platelets: effect of adenylate cyclase activity Thromb Res 19 1980 225 237
39. Schousboe I. Purification, characterization and identification of an agglutinin in human serum Biochim Biophys Acta 579 1979 396 408
40. Wurm H. β2-glycoprotein I (apolipoprotein H) interactions with phospholipid vesicles Int J Biochem 16 1984 511 515
41. Krøll J. Larsen J.K. Loft H. DNA-binding proteins in Yoshida ascites tumor fluid Biochem Biophys Acta 434 1976 490 501
42. Polz E. Wurm H. Kostner G.M. Investigations on β2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fractions Int J Biochem 11 1980 265 270
43. Polz E. Kostner G.M. The binding of β2-glycoprotein I to human serum lipoproteins: distribution among density fractions FEBS Lett 102 1979 183 186
44. Schousboe I. β2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway Blood 66 1985 1086 1091
45. Nimpf J. Bevers E.M. Bomans P.H.H. Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I Biochim Biophys Acta 884 1986 142 149
46. Nimpf J. Wurm H. Kostner G.M. β2-glycoprotein I (apo-H) inhibits the release reaction of human. platelets during ADP-induced aggregation Atherosclerosis 63 1987 109 114
47. Gharavi A.E. Sammaritano L.R. Wen J. Induction of antiphospholipid autoantibodies by immunization with β2-glycoprotein I (apolipoprotem H) J Clin Invest 90 1992 1105 1109
48. Kouts S. Wang M.-X. Adelstein S. Immunization of a rabbit with β2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies J Immunol 155 1995 958 966
49. Pierangeli S.S. Harris E.N. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human β2-glycoprotein I or anti-cardiolipin antibodies alone Clin Exp Immunol 93 1993 269 272
50. Martinuzzo M.E. Forastiero R.R. Carreras L.O. Anti-β2-glycoprotein I antibodies: detection and association with thrombosis Br J Haematol 89 1995 397 402
51. Steinkasserer A. Barlow P.N. Willis A.C. Activity, disulphide mapping and structural modelling of the fifth domain of human β2-glycoprotein I FEBS Lett 313 1992 193 197
52. Hunt J.E. Simpson R.J. Krills S.A. Identification of a region of β2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity Proc Natl Acad Sci USA 90 1993 2141 2145
53. Hunt J. Krilis S. The fifth domain of β2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies J Immunol 152 1994 653 659
54. Wang M.X. Kandiah D.A. Ichikawa K. Epitope specificity of monoclonal anti-β2-glycoprotein I antibodies derived from patients with the anti-phospholipid syndrome J Immunol 155 1995 1629 1636
55. Arvieux J. Roussel B. Jacob M.C. Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigen J Immunol Methods 143 1991 223 229
56. Viard J.-P. Amoura Z. Bach J.-F. Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus Am J Med 93 1992 181 186
57. Keeling D.M. Wilson A.J. Mackie I.J. Some antiphospholipid antibodies bind to beta 2-glycoprotein I in the absence of phospholipid Br J Haematol 82 1992 571 574
58. Matsuura E. Igarashi Y. Yasuda T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface J Exp Med 179 1994 457 462
59. Onyiriuka E.C. Hersh I.S. Herti W. Surface modification of polystyrene by γ-irradiation Appl Spectrosc 44 1990 808 814
60. Roubey R.A.S. Eisenberg R.A. Harper M.F. Anticardiolipin autoantibodies recognize β2-glycoprotein I in the absence of phospholipid J Immunol 154 1995 954 960
61. Wagenknecht D.R. McIntyre J.A. Changes in β2-glycoprotein I antigenicity induced by phospholipid binding Thromb Haemostasis 69 1993 361 365
62. Gao B. Esnouf M.P. Multiple interactive residues of recognition: elucidation of discontinuous epitopes with linear peptides J Immunol 157 1996 183 188
63. Monestier M. Kandiah D.A. Kouts S. Monoclonal antibodies from NZW X BXSB F1 mice to β2-glycoprotein I and cardiolipin: species specificity and charge-dependent binding J Immunol 156 1996 2631 2641
64. Hang L.M. Izui S. Dixon F.J. (NZW X BXSB) Fl hybrid: a model of acute lupus and coronary disease with myocardial infarction J Exp Med 154 1996 216 221
65. Hashimoto Y. Kawamura M. Ichikawa K. Anticardiolipin antibodies in NZW X BXSB Fl mice: a model of anti-phospholipid syndrome J Immunol 149 1992 1063 1068
66. Feinstein D.I. Rapaport S.I. Acquired inhibitors of blood coagulation Prog Hemostas Thromb 1 1972 75 95
67. Conley C.L. Hartmann R.C. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus J Lab Clin Invest 13 1952 621 622
68. Laurell A.B. Nilsson I.M. Hypergammaglobulinemia, circulating anticoagulant, and biological false positive Wassermann reaction: a study of two cases J Lab Clin Med 49 1957 694 707
69. Exner T. Triplett D. Lupus anticoagulants: characteristics, methods of laboratory detection and some clinical associations Harris E.N. Exner T. Hughes G.R.V. Asherson R.A. Phospholipid binding antibodies 1991 CRC Boca Ratan, FL 141 158
70. Thiagarajan P. Shapiro S.S. DeMarco L. Monoclonal immunoglobulin Mλ coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant J Clin Invest 66 1980 397 405
71. Galli M. Beguin S. Lindhout T. Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with lupus anticoagulants Br J Haematol 72 1989 549 555
72. Yin E.T. Gaston L.W. Purification and kinetic studies of a circulating anticoagulant in a suspected case of lupus erythematosus Thromb Haemorrh 14 1985 88 115
73. Pengo V. Thiagarajan P. Shapiro S.S. Immunological specificity and mechanism of action of IgG lupus anticoagulants Blood 70 1996 69 76
74. Roubey R.A.S. Pratt C.W. Buyon J.P. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I J Clin Invest 90 1992 1100 1104
75. Exner T. Sahman N. Trudinger B. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column Biochem Biophys Res Commun 155 1988 1001 1007
76. McNeil H.P. Chesterman C.N. Krilis S.A. Anticardiolipin antibodies and lupus anticoagulants comprise antibody subgroups with different phospholipid binding characteristics Br J Haematol 73 1989 506 513
77. Oosting J.D. Derksen R.H.W.M. Entjies H.T.I. Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein I Thromb Haemost 67 1992 499 502
78. Galli M. Comfurius P. Barbui T. Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies Thromb Haemost 68 1992 297 300
79. Ozawa N. Makino T. Matsubayashi H. β2-glycoprotein I-dependent and independent binding of anticardiolipin antibodies in patients with recurrent spontaneous abortions J Clin Lab Anal 8 1994 255 259
80. Frick P.G. Acquired circulating anticoagulants in systemic collagen disease autoimmune thromboplastin deficiency Blood 10 1955 691 706
81. Loeliger A. Prothrombin as co-factor in the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 3 1959 237 256
82. Bajaj S.P. Rapaport S.I. Fierer D.S. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombineia-lupus anticoagulant syndrome Blood 61 1983 684 692
83. Bajaj S.P. Rapaport S.I. Barclay S. Acquired hypoprothrombinernia due to nonneutralizing antibodies to prothrombin: mechanism and management Blood 65 1985 1538 1543
84. Edson J.R. Vogt J.M. Hasegawa D.K. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors Blood 64 1984 807 816
85. Fleck R.A. Rapaport S.I. Rao L.V. Antiprothrombin antibodies and the lupus anticoagulant Blood 72 1988 512 519
86. Bevers E.M. Galli M. Barbui T. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb Haemost 66 1991 629 632
87. Chap 2 Ichinose A. Davie E.W. The blood coagulation factors: their cDNAs, genes, and expression Colman R.W. Hirsh J. Marder V.J. Salzman E.W. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 3rd ed 1994 Lippincott Philadelphia 19 54
88. Chap 13 Broze G.J. Miletich J.P. Biochemistry and physiology of protein C, protein S, and thrombomodulin Colman R.W. Hirsh J. Marder V.J. Hemostasis and thrombosis: basic principles and clinical practice ed 3 1994 Lippincott Philadelphia 259 276
89. Oosting J.D. Derksen R.H.W.M. Bobbink I.W.G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for theirpathogenic mechanism? Blood 81 1993 2618 2625
90. [abstract] Comp P.C. DeBault L.E. Esmon N.L. Human thrombomodulin is inhibited by IgG from two patients with nonspecific anticoagulants Blood 62 1983 299a
91. Freyssinet J.M. Cazenave J.P. Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis Thromb Haemost 58 1987 679 681
92. Cariou R. Tobelum G. Bellucci S. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells: inhibition of thrombomodulin-dependent protein C activation Thromb Haemost 60 1988 54 58
93. Marcimak K. Romond E. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant Blood 74 1989 2426 2432
94. Malia R.G. Kitchen S. Greaves M. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies Br J Haematol 76 1990 101 107
95. de Groot P.G. Oosting J.D. Derksen R.H.W.M. Antiphospholipid antibodies: specificity and pathophysiology Baillieres Clin Haematol 6 1993 691 709
96. Schorer A.E. Duane P.G. Woods V.L. Some antiphospholipid antibodies inhibit phospholipase A2 activity J Lab Clin Med 120 1992 67 77
97. Reges H. Dearing L. Shoenfeld Y. Antiphospholipid antibodies: a critique of their heterogeneity and hegemony Semin Thromb Hemost 20 1994 89 100
98. Mackworth-Young C.G. Antiphospholipid antibodies and disease Br J Rheumatol 34 1995 1009 1030
99. Gharavi A.E. Harris E.N. Lockshin M.D. IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus Ann Rheum Dis 47 1988 286 290
100. Tsutsumi A. Koike T. Ichikawa K. IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus J Rheumatol 15 1988 1764 1767
101. Tiikkainen U. Wangel A. Appleton S.L. Subclasses of IgG anticardiolipin antibodies in patients with systemic lupus erythematosus Scand J Immunol 34 1991 265 271
102. Vermylen J. Arnout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexex? J Lab Clin Med 120 1992 10 12
103. Janoff A.S. Rauch J. The structural specificity of antiphospholipid antibodies in autoimmune disease Chem Phys Lipids 40 1986 315 332
104. Nelson R.A. Jr Mayer M.M. Immobilization of Treponema pallidum in vitro by antibody produced in syphilis infection J Exp Med 89 1949 369 393
105. Lee S.L. Sanders M. A disorder of blood coagulation in systemic lupus erythematosus J Clin Invest 34 1955 1814 1822
106. Lechner K. Acquired inhibitors in nonhemophilic patients Haemostasis 3 1974 65 93
107. Lee S.L. Miotti A.B. Disorders of hemostatic function in patients with systemic lupus erythematosus Semin Arthritis Rheum 4 1975 241 252
108. Schleider M.A. Nachman R.L. Jaffe E.A. A clinical study of the lupus anticoagulant Blood 48 1976 499 509
109. Harris E.N. Gharavi A.E. Boey M.L. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus Lancet 2 1983 1211 1214
110. Colaco C.B. Male D.K. Antiphospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity Clin Exp Immunol 59 1985 449 456
111. Koike T. Sueishi M. Funaki H. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus Clin Exp Immunol 56 1984 193 199
112. Harris E.N. Gharavi A.E. Wasley G.D. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders J Infect Dis 157 1988 23 31
113. Asherson R.A. Khamashta M.A. Ordi-Ros J. The primary antiphospholipid syndrome: major clinical and serological features Medicine 68 1989 366 374
114. Strandberg Pedersen N. Orum O. Mouritsen S. Enzyme linked immunosorbent assay for detection of antibodies to the veneral disease research laboratory (VDRL) antigen in syphilis J Clin Microbiol 25 1987 1711 1716
115. Harris E.N. Serological detection of antiphospholipid antibodies Stroke 23 1992 I
116. Loizou S. McCrea J.D. Rudge A.C. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results Clin Exp Immunol 62 1985 738 745
117. Stewart M.W. Etches W.S. Russel A.S. Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificity Thromb Haemost 70 1993 603 607
118. Eschwege V. Laude I. Toti F. Detection of bilayer phospholipid-binding antibodies using flow cytometry Clin Exp Immunol 103 1996 171 175
119. Bick R.L. Baker W.E. Anticardioiipin antibodies and thrombosis Hematol Oncol Clin North Am 6 1992 1287 1299
120. Jouhikainen T. Julkunen H. Vaarala O. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: Comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients Blood Coagul Fibrinolysis 3 1992 407 414
121. Lockshin M.D. Antiphospholipid antibody syndrome JAMA 268 1992 1451 1453
122. Triplett D.A. Coagulation assays for the lupus anticoagulant: review and critique of current methodology Stroke 23 Suppl 1 1992 I
123. Rauch J. Tannenbaum M. Janoff A.S. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids Thromb Haemost 62 1989 892 896